Stocktoria
Astera Labs, Inc. ALAB
Astera Labs, Inc. financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $852.5M | $396.3M | $115.8M |
| Gross profit | $645.3M | $302.7M | $79.8M |
| R&D expense | $304.0M | $200.8M | $73.4M |
| Operating income | $173.4M | -$116.1M | -$29.5M |
| Income tax | -$981,000 | $1.6M | $3.3M |
| Net income | $219.1M | -$83.4M | -$26.3M |
| EPS (diluted) | $1.22 | $-0.64 | $-0.71 |
| Operating cash flow | $319.3M | $136.7M | -$12.7M |
| Free cash flow | $281.8M | $102.4M | -$15.5M |
| Cash & equivalents | $167.6M | $79.6M | $45.1M |
| Inventory | $59.0M | $43.2M | $24.1M |
| Total assets | $1.5B | $1.1B | $196.3M |
| Total liabilities | $168.2M | $89.7M | $38.9M |
| Shareholders' equity | $1.4B | $964.8M | -$97.7M |
Growth · year-over-year · Revenue CAGR 171.3%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | +115.1% | +242.2% | — |
| Free cash flow growth | +175.1% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.